Jiangang Zou

Pleased to introduce our LBBP-RESYNC trial online today in #JACC First head to head comparison of LBBP vs BiVP in CRT for nonischemic patients. Significantly greater increase in LVEF with LBBP at 6 month! @MdHuang @KennethEllenbo1 @DrMGold1 @JasperZouMD jacc.org/doi/10.1016/j.…

Our study showing early LBBP resynchronization at index diagnosis for HFmfEF with LBBB significantly improves LVEF and clinical outcomes at 6 months compared to GDMT alone! Restoring LVEF back to normal and reduces HF hospitalization @JasperZouMD @hrs_journal

Great to be finally back at #HRS2023 after three years, seeing old friends, meeting new ones and constant learning about the field. So privileged to be part of this fascinating field.

Great China-US session hosted by legend @MdHuang at the 6th Symposium of His-Purkinje Conduction System Pacing (HPCSP). Good to meet colleagues and exchange ideas: @jgzoumd Keping Chen @cha_yongmei @gauravaupadhyay @psharmadoc @dontdisGD

@Nishaki1 @ikutinsky1 @SimonDixonMBChB @IvanHansonMD @AkhilGulati @PamelaMasonEP @drkuldeep_shah @EladAnter @shivkumarmd @dhaines901 @DrCJBradley @DrBradleyKnight Dave is my mentor in UVA in 2002-2003. Terrific water skiing.

I can assure you, not many EPs or even ICs 😛. @ikutinsky1 @SimonDixonMBChB @IvanHansonMD @AkhilGulati @PamelaMasonEP @drkuldeep_shah @EladAnter @shivkumarmd @dhaines901 @DrCJBradley @DrBradleyKnight

LBBP is a novel and revolutionary physiological pacing modality, which is expected to be the preferred strategy of resynchronization therapy for patients with heart failure and left bundle branch block.

Thanks to the hard work of all collaborators! Looking forward to bigger outcome-based RCTs to come! Thoughtful editorial by @Hisdoc1 shining light on what’s needed ahead. @MihailChelu @Marek_Jastrz_EP @DrRoderickTung @EP_mom1 @ZacharyWhinnett @psharmadoc @gauravaupadhyay

Pleased to introduce our LBBP-RESYNC trial online today in #JACC First head to head comparison of LBBP vs BiVP in CRT for nonischemic patients. Significantly greater increase in LVEF with LBBP at 6 month! @MdHuang @KennethEllenbo1 @DrMGold1 @JasperZouMD jacc.org/doi/10.1016/j.…

Privileged to present the LBBP-RESYNC pilot trial at the late breaking clinical trial session at #HRS2022 on behalf of Dr. Jiangang Zou. LBBP-RESYNC is the first RCT showing LBBP’s superior improvement of LVEF compared to BiV-CRT. @HRSonline